INS and diabetes mellitus: It is noteworthy here to consider assessment of serum insulin, as shown by Yousef and colleagues, 2022 [62] together with blood glucose and histopathological alterations as a marker to assess the functional efficiency of transplanted MSCs in treatment of DM either in preclinical or clinical studies.